Optimization of the Synthetic Process of Dapagliflozin: Microchannel Continuous Flow Enables Minute-Scale Reactions with Crude Product Purity > 90%
This dapagliflozin synthesis case adopts microchannel continuous flow microreactor for stereoselective reduction. It completes the reaction within minutes and obtains crude product purity above 90%. Superior heat-mass transfer cuts side reactions and scale-up risks vs traditional batch processes. Our team provides EPC, process optimization and skid-mounted microreactor services for pharmaceutical API manufacturing.
Oct 30,2026











